Polysaccharide-protein conjugates: a new generation of vaccines.
Robbins
J B
JB
Laboratory of Developmental and Molecular Immunity, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.
Schneerson
R
R
D000818:Animals; D016667:Bacterial Capsules; D001428:Bacterial Vaccines; D006192:Haemophilus Infections / Q000517:prevention & control; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae / Q000276:immunology; D006801:Humans; D007410:Intestinal Diseases / Q000517:prevention & control; D008581:Meningitis / Q000517:prevention & control; D011135:Polysaccharides, Bacterial; D012475:Salmonella / Q000276:immunology; D018805:Sepsis / Q000517:prevention & control; D012760:Shigella / Q000276:immunology; D013745:Tetanus Toxoid; D014435:Typhoid Fever / Q000517:prevention & control; D014436:Typhoid-Paratyphoid Vaccines; D014612:Vaccines; D014614:Vaccines, Synthetic
D001428:Bacterial Vaccines; D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; D011135:Polysaccharides, Bacterial; D013745:Tetanus Toxoid; D014436:Typhoid-Paratyphoid Vaccines; D014612:Vaccines; D014614:Vaccines, Synthetic